DK0873136T3 - Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme - Google Patents
Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af sammeInfo
- Publication number
- DK0873136T3 DK0873136T3 DK96939501T DK96939501T DK0873136T3 DK 0873136 T3 DK0873136 T3 DK 0873136T3 DK 96939501 T DK96939501 T DK 96939501T DK 96939501 T DK96939501 T DK 96939501T DK 0873136 T3 DK0873136 T3 DK 0873136T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- factor
- specific immune
- date
- methods
- Prior art date
Links
- 230000002708 enhancing effect Effects 0.000 title 1
- GHUJOXJDUAROKJ-UHFFFAOYSA-N 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde Chemical compound CC1C(C=O)=CNC=C1C=O GHUJOXJDUAROKJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 230000005284 excitation Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US595995P | 1995-10-27 | 1995-10-27 | |
| PCT/US1996/017240 WO1997015324A1 (en) | 1995-10-27 | 1996-10-25 | High fluorescence specific immune enhancing factor and methods of use for same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0873136T3 true DK0873136T3 (da) | 2005-01-24 |
Family
ID=21718568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96939501T DK0873136T3 (da) | 1995-10-27 | 1996-10-25 | Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6120777A (da) |
| EP (1) | EP0873136B1 (da) |
| JP (1) | JP2000505056A (da) |
| AT (1) | ATE279207T1 (da) |
| AU (1) | AU726344B2 (da) |
| CA (1) | CA2235599A1 (da) |
| DE (1) | DE69633635T2 (da) |
| DK (1) | DK0873136T3 (da) |
| WO (1) | WO1997015324A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100680014B1 (ko) * | 1997-10-03 | 2007-02-09 | 갈레니카 파마슈티칼스 인크. | 이민 형성 폴리사카라이드, 이의 제조 방법 및 이것의 아쥬반트 및 면역자극제로서의 용도 |
| GB0326439D0 (en) * | 2003-11-13 | 2003-12-17 | Imp College Innovations Ltd | Methods |
-
1996
- 1996-10-25 WO PCT/US1996/017240 patent/WO1997015324A1/en not_active Ceased
- 1996-10-25 DK DK96939501T patent/DK0873136T3/da active
- 1996-10-25 AT AT96939501T patent/ATE279207T1/de not_active IP Right Cessation
- 1996-10-25 JP JP9516852A patent/JP2000505056A/ja active Pending
- 1996-10-25 EP EP96939501A patent/EP0873136B1/en not_active Expired - Lifetime
- 1996-10-25 CA CA002235599A patent/CA2235599A1/en not_active Abandoned
- 1996-10-25 DE DE69633635T patent/DE69633635T2/de not_active Expired - Fee Related
- 1996-10-25 US US08/849,024 patent/US6120777A/en not_active Expired - Fee Related
- 1996-10-25 AU AU76654/96A patent/AU726344B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0873136A4 (en) | 2001-11-07 |
| AU7665496A (en) | 1997-05-15 |
| WO1997015324A1 (en) | 1997-05-01 |
| ATE279207T1 (de) | 2004-10-15 |
| EP0873136B1 (en) | 2004-10-13 |
| US6120777A (en) | 2000-09-19 |
| DE69633635D1 (de) | 2004-11-18 |
| EP0873136A2 (en) | 1998-10-28 |
| DE69633635T2 (de) | 2006-03-09 |
| AU726344B2 (en) | 2000-11-02 |
| CA2235599A1 (en) | 1997-05-01 |
| JP2000505056A (ja) | 2000-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL134392A0 (en) | Vaccine against hpv | |
| BR9814487A (pt) | "vacina" | |
| DE69637642D1 (de) | Und kombinierte zusammensetzungen und deren verwendung | |
| TR199801722T2 (xx) | Peptit imm�nojenler. | |
| ATE231917T1 (de) | Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine | |
| ATE454163T1 (de) | Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren | |
| DK0817846T3 (da) | Intracellulært domæne af HER-2/neu proteinet til forebyggelse eller behandling af maligniteter | |
| WO2003045128A3 (en) | SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO | |
| ATE125157T1 (de) | Methoden und zusammensetzungen zur impfung gegen hiv. | |
| NO20013701L (no) | HER-2/neu-fusjonsproteiner | |
| NO924780L (no) | Ekspresjon av spesifikke immunogener ved bruk av virusantigener | |
| DE69431404D1 (de) | Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe | |
| DE69429723D1 (de) | Stressproteine und ihre verwendung | |
| JPS56131523A (en) | Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigen | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| MX9801159A (es) | Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob. | |
| DK0555276T3 (da) | Immunogene komplekser, især iscomer | |
| WO2000056901A3 (en) | Linear and circular expression elements | |
| AU2316892A (en) | Multiple emulsions and methods of preparation | |
| DE69727595D1 (de) | Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung | |
| NO20024571D0 (no) | Immunoterapeutiske fremgangsmåter og blandinger | |
| AU691995B2 (en) | Interference-suppressing reagent specific to certain classes of antibodies | |
| EP0602046A4 (en) | DETECTING THE MAMMAL VIRUS WEAK VIRUS. | |
| ES2196150T3 (es) | Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. | |
| DE69229269D1 (de) | Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik |